Dec 23, 2020 21:05 UTC
Urovant Sciences Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB) IRVINE, Calif. & BASEL, Switzerland (Business Wire) Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for once-daily 75 mg GEMTESA® (vibegron), a beta-3 adrenergic receptor (β3) agonist, for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence (UUI), urgency, and urinary frequency in adults. This approval marks the first new oral branded OAB medication approved by the FDA since 2012, and it is the first product approval for Urovant Sciences.
GrowGeneration Acquires Assets of Canopy Crop Management
News provided by
Share this article
Share this article
Company expands its portfolio of private label products within the nutrient and additive space, acquiring the Power SI brand of silicic acid-enriched fertilizers
DENVER, Colo., Dec. 23, 2020 /PRNewswire/ -
GrowGeneration Corp. (NASDAQ: GRWG), ( GrowGen or the Company ) the nation s largest chain of specialty hydroponic and organic garden centers, today announced it has acquired Southern California-based Canopy Crop Management and its complete portfolio of products, including the Power SI brand of silicic acid-enriched fertilizers. Established in 2019, Canopy Crop Management is recognized as the industry s leading silicic acid company. Power SI will continue to be sold through Canopy Crop Management to all hydroponic retail stores including Grow Generation s 39 locations.
Great Panther Files NI 43-101 Technical Report for the Guanajuato Mine Complex morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
[December 23, 2020]
The security solution is an advanced application of artificial intelligence (AI) and machine vision technology
OMNIQ was selected due to its technologyâs superior, real-time accuracy and unique features
OMNIQâs patented AI-based technology is trusted in highly sensitive locations
SALT LAKE CITY, Dec. 23, 2020 (GLOBE NEWSWIRE) OMNIQ Corp. (OTCQB: OMQS) (âOMNIQâ or âthe Companyâ), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced that the Company has received an order to provide its AI-based machine vision safety solution to a top, non-U.S., security authority for the protection of a government leader.
OMNIQâs safety system is a ground-breaking cloud/on-premises-based security solution for Homeland Security, Safe City and Safe Campus applications that uses unique, patented AI-based computer vision technology and software to gather real-time data in order to control access, provide i
22 dicembre 2020 12:58
Fonte: Adnkronos
#ict
STUTTGART, Germany and BENGALURU, India, Dec. 22, 2020 /PRNewswire/ Daimler AG and Infosys (NYSE: INFY), today announced a long-term strategic partnership for a technology-driven IT infrastructure transformation. After the receipt of all regulatory approvals, Daimler AG will transform its IT operating model and infrastructure landscape across workplace services, service desk, data center, networks and SAP Basis together with Infosys. The partnership will enable the company to deepen its focus on software engineering and to establish a fully scalable on-demand digital IT infrastructure and anytime-anywhere workplace. The collaboration will empower Daimler to strengthen its IT capabilities, and Infosys, its automotive expertise.